Abstract
Purpose: This study evaluates a genotype/phenotype relationship between developmental verbal dyspraxia (DVD) and the common, missense mutation of the galactose-l-phosphate uridyltransferase gene, Q188R, in patients with classic galactosemia (G/G).
Methods: As part of this study, we devised a questionnaire for “speech problems” to be completed by the patient's clinician. To validate the questionnaire and determine its accuracy in detecting DVD, we analyzed questionnaire responses for 21 patients by testing them independently and directly for DVD through a speech pathologist blinded to the patients' genotype.
Results: We found that the questionnaire had a sensitivity of 0.56 and a specificity of 0.75. We then calculated the prevalence of DVD for a larger set of 113 patients with G/G galactosemia whose biochemical phenotype, molecular genotypes, and clinical status were known. The prevalence of “speech problems” from raw data were 50 of 113 (44.2%). After adjusting for misclassification, 43 (38.1%) were classified as cases of DVD. Using multivariate, logistic, regression analyses we found a significant interaction between genotype and mean red blood cell (RBC) galactose-1-phosphate (Gal-1-P). When corrected, using mean RBC Gal-1-P > 3.28 mg%, the Q188R/Q188R genotype was the best predictor of DVD. There was a significant risk (odds ratio = 9.6, p = 0.0504) of having DVD associated with homozygosity for Q188R compared with other genotypes.
Conclusions: We conclude that homozygosity for Q188R mutations in the GALT gene is a significant risk factor for DVD. However, poor metabolic control obviates this relationship as indicated by RBC Gal-1-P greater than 3.28 mg%.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robertson, A., Singh, R., Guerrero, N. et al. Outcomes analysis of verbal dyspraxia in classic galactosemia. Genet Med 2, 142–148 (2000). https://doi.org/10.1097/00125817-200003000-00005
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1097/00125817-200003000-00005
Keywords
This article is cited by
-
Understanding the patient experience of Classic Galactosemia in pediatric and adult patients: increased disease burden, challenges with daily living, and how they evolve over time
Journal of Patient-Reported Outcomes (2023)
-
Biochemical changes and clinical outcomes in 34 patients with classic galactosemia
Journal of Inherited Metabolic Disease (2018)
-
Galactose and its Metabolites Deteriorate Metaphase II Mouse Oocyte Quality and Subsequent Embryo Development by Disrupting the Spindle Structure
Scientific Reports (2017)
-
Sweet and sour: an update on classic galactosemia
Journal of Inherited Metabolic Disease (2017)
-
Appropriateness of newborn screening for classic galactosaemia: a systematic review
Journal of Inherited Metabolic Disease (2016)